The first fallout - PharmaTimes Magazine March 2021
Taking a look at the recent dispute between the EU Commission and AstraZeneca over the ins and outs of its contract, Stuart Evans, commercial litigation expert and partner at law firm BLM, examines what this could represent for EU/UK cross-border
by Stuart Evans
https://www.pharmatimes.com/magazine/2021/april_2021/the_first_fallout